Where the Hormones Hold the Weight

Cells stop responding properly to insulin, so glucose and fat storage rise together. It commonly drives hunger, belly fat and weight regain.

The brain stops hearing the fat-cell satiety signal clearly. Appetite rises even when stored energy is already high.

Low thyroid hormone slows metabolic rate and fluid turnover. Patients may feel tired, cold, constipated and unable to lose weight.

Autoimmune thyroid inflammation can reduce thyroid output over time. Weight gain often appears with fatigue, puffiness and fluctuating TSH.

PCOS links insulin resistance with ovarian androgen excess. Irregular periods, acne, facial hair and central weight gain are common.

Excess cortisol shifts fat to the abdomen, face and upper back. It can also raise blood pressure, glucose and muscle weakness.

Low sex-hormone signaling reduces muscle mass and energy expenditure. It may worsen belly fat, fatigue and low drive.

High prolactin can disturb reproductive hormones and weight regulation. It may also cause menstrual changes, infertility or galactorrhoea.

Low GH signaling reduces lean mass and fat breakdown. Adults may develop abdominal fat, fatigue and poor exercise recovery.

Poor cortisol rhythm can disturb sleep, appetite and glucose control. Stress eating and resistant abdominal weight may follow.

This is the clustering of abdominal obesity, high BP, high glucose and abnormal lipids. It predicts diabetes and heart-risk progression.

Excess liver fat reflects insulin resistance and energy overflow. It can worsen inflammation, triglycerides and metabolic slowdown.

Insulin resistance and beta-cell strain lead to chronic high glucose. Weight management must protect muscle while improving glycaemic control.

Glucose regulation is already abnormal before diabetes appears. Early intervention can reverse the trajectory if biology is treated seriously.

Insulin remains high for long periods, pushing hunger and fat storage. It often precedes diabetes by years.

Relative estrogen excess may cause fluid retention, cravings and cycle-related weight swings. Balance with progesterone and insulin matters.

Low testosterone reduces muscle, strength and basal energy use. It can worsen insulin resistance and abdominal fat.

Fluctuating ovarian hormones change sleep, appetite and fat distribution. Many women gain weight before final menopause.

Lower estrogen changes fat partitioning and insulin sensitivity. Visceral fat and cardiometabolic risk may rise.

Age-related androgen decline can reduce muscle and increase central fat. Training, sleep and metabolic correction become central.

TSH may rise before classic thyroid failure appears. Some patients develop fatigue, coldness and stubborn weight gain.

High thyroid output may cause weight loss but also muscle loss and palpitations. Treatment can later reveal rebound weight gain.

Low vitamin D is linked with inflammation, insulin resistance and muscle weakness. Correction supports but does not replace obesity treatment.

DHEA is an adrenal hormone affecting energy and androgen balance. Both excess and deficiency may disturb metabolic symptoms.

Poor melatonin signaling damages sleep timing and appetite hormones. Late-night eating and insulin resistance can worsen.

Ghrelin is a hunger signal that rises with dieting and poor sleep. It can make weight loss feel biologically defended.

Low adiponectin reduces fat oxidation and insulin sensitivity. It is common in visceral obesity.

IGF-1 reflects growth-hormone axis activity and nutrition. Imbalance may affect muscle, fat distribution and recovery.

Excess androgen activity can cause unwanted hair growth and acne. The same biology often overlaps with insulin resistance.

A history of pregnancy diabetes predicts future type 2 diabetes risk. Postpartum metabolic follow-up is essential.

Pregnancy, sleep loss and lactation shifts can reset appetite and metabolism. Treatment must be gentle and structured.

Positive antibodies show immune activity against thyroid tissue. Thyroid function can fluctuate before permanent hypothyroidism appears.

Small pituitary tumors can alter prolactin, cortisol or other hormonal axes. Weight effects depend on which hormone is disturbed.

Damage or dysfunction in brain appetite centers causes severe biological hunger. Standard dieting is usually inadequate alone.

Glucose drops after meals can trigger hunger, shaking and cravings. Meal composition and insulin dynamics need correction.

Liver fat alters insulin, lipids and inflammatory signaling. Treating the liver improves the wider metabolic network.

Repeated oxygen drops and sleep fragmentation raise cortisol and insulin resistance. Treating sleep often improves weight response.

Abnormal cholesterol or triglycerides often reflect insulin resistance. It increases cardiovascular risk alongside obesity.

Excess insulin, cortisol and visceral fat can raise vascular tone and sodium retention. Weight treatment may lower pressure burden.

Fat tissue can become an inflammatory organ. This makes hunger, fatigue and insulin resistance biologically reinforced.